# The Effects of Botulinum Toxin on Oral Aperture in Patients With Scleroderma

> **NCT04523506** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 17 (actual)

## Conditions studied

- Scleroderma

## Interventions

- **BIOLOGICAL:** Botulinum toxin(Botox)

## Key facts

- **NCT ID:** NCT04523506
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-08
- **Primary completion:** 2021-04-22
- **Final completion:** 2021-04-22
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04523506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04523506, "The Effects of Botulinum Toxin on Oral Aperture in Patients With Scleroderma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04523506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*